[Hypertension secondary to primary aldosteronism].
Omura
Masao
M
Division of Endocrinology & Metabolism, Department of Internal Medicine, Social Insurance Central General Hospital.
Saito
Toshikazu
T
Saito
Jun
J
Soyama
Akiko
A
Nishikawa
Tetsuo
T
D000236:Adenoma / Q000150:complications / Q000378:metabolism; D000310:Adrenal Gland Neoplasms / Q000150:complications / Q000378:metabolism; D000315:Adrenalectomy; D000450:Aldosterone / Q000378:metabolism; D000959:Antihypertensive Agents / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006801:Humans; D006929:Hyperaldosteronism / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D006973:Hypertension / Q000209:etiology*; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D011379:Prognosis
D000959:Antihypertensive Agents; D000451:Mineralocorticoid Receptor Antagonists; D000450:Aldosterone